These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 6397984)
41. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Shimokawa H; Aarhus LL; Vanhoutte PM Circ Res; 1987 Aug; 61(2):256-70. PubMed ID: 3113760 [TBL] [Abstract][Full Text] [Related]
42. Effects of oxyhemoglobin on vasoconstriction in response to 5-hydroxytryptamine in isolated, perfused canine basilar arteries. Orz YI; Tsuji T; Aoki T; Yen Y; Chiba S; Kobayashi S Neurosurgery; 1998 Nov; 43(5):1176-84. PubMed ID: 9802861 [TBL] [Abstract][Full Text] [Related]
43. Serotonin and vascular reactivity. Van Nueten JM; Janssens WJ; Vanhoutte PM Pharmacol Res Commun; 1985 Jul; 17(7):585-608. PubMed ID: 2931729 [TBL] [Abstract][Full Text] [Related]
44. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Feniuk W; Humphrey PP; Perren MJ; Watts AD Br J Pharmacol; 1985 Nov; 86(3):697-704. PubMed ID: 2933110 [TBL] [Abstract][Full Text] [Related]
45. 5-HT receptors mediating contractions of the isolated human coronary artery. Bax WA; Renzenbrink GJ; Van Heuven-Nolsen D; Thijssen EJ; Bos E; Saxena PR Eur J Pharmacol; 1993 Aug; 239(1-3):203-10. PubMed ID: 7693489 [TBL] [Abstract][Full Text] [Related]
46. Antihypertensive properties of ketanserin (R 41 468). Vanhoutte PM; Van Nueten JM; Symoens J; Janssen PA Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821 [TBL] [Abstract][Full Text] [Related]
47. Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugs. Robertson JI J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S48-53. PubMed ID: 1717773 [TBL] [Abstract][Full Text] [Related]
48. Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation. McLennan PL; Taylor DA Eur J Pharmacol; 1984 Sep; 104(3-4):313-8. PubMed ID: 6499925 [TBL] [Abstract][Full Text] [Related]
49. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Chester AH; Martin GR; Bodelsson M; Arneklo-Nobin B; Tadjkarimi S; Tornebrandt K; Yacoub MH Cardiovasc Res; 1990 Nov; 24(11):932-7. PubMed ID: 2272071 [TBL] [Abstract][Full Text] [Related]
51. Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Doyle VM; Creba JA; Rüegg UT; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):98-103. PubMed ID: 2944005 [TBL] [Abstract][Full Text] [Related]
52. Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases. De Cree J; Leempoels J; Demoen B; Roels V; Verhaegen H J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S26-8. PubMed ID: 2412051 [TBL] [Abstract][Full Text] [Related]
53. The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases. De Cree J; Leempoels J; Demoen B; Roels V; Verhaegen H Agents Actions; 1985 Jul; 16(5):313-7. PubMed ID: 2931964 [TBL] [Abstract][Full Text] [Related]
54. 5-Hydroxytryptamine and thromboxane A2 in ischaemic heart disease. De Clerck F; Janssen PA Blood Coagul Fibrinolysis; 1990 Jun; 1(2):201-9. PubMed ID: 2130932 [TBL] [Abstract][Full Text] [Related]
55. Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Chester AH; Allen SP; Tadjkarimi S; Yacoub MH Circulation; 1993 Mar; 87(3):874-80. PubMed ID: 8443908 [TBL] [Abstract][Full Text] [Related]
56. [Serotoninergic receptors and cardiovascular diseases]. Hong E; Castillo C; Flores E; Mercedes F Gac Med Mex; 1994; 130(3):131-3. PubMed ID: 7657075 [TBL] [Abstract][Full Text] [Related]
57. 5-Hydroxytryptamine and the metabolism of arachidonic acid by the lipoxygenase and cyclooxygenase of washed human platelets. Dragan YP; Ellis EF Biochem Pharmacol; 1990 Jul; 40(2):309-14. PubMed ID: 2142882 [TBL] [Abstract][Full Text] [Related]